You are here

Q-Biologicals (Flanders) acquired by Amatsigroup (France)

Amatsigroup, a French provider of pharmaceutical development services, has acquired Q-Biologicals. This spin-off of Flanders’ VIB life sciences institute offers process development and bio-manufacturing services, supporting Amatsigroup’s expansion plans.

Specialist in pharmaceutical development
Q-Biologicals specializes in bio-products for numerous applications in therapeutics, vaccines and diagnostics. Some examples include recombinant proteins, antibodies, viruses and live cells. 20 employees strong, the VIB spin-off has already completed an impressive 75 R&D projects since it was established in 2011, and generated a turnover of EUR 4 million in 2015.

Backing expansion plans
By acquiring Q-Biologicals, Amatsigroup aims to drive its growth and international expansion strategy. The French company will be leveraging its new subsidiary’s strengths as a platform to tap into the synthetic biology applications market. Additionally, thanks to the acquisition, Amatsigroup now boasts an integrated and innovative offering for the development of new biological medicines.

Reported by
De Vlaamse Ondernemer
10 March 2016

More news about Flanders?

  • Regular updates
  • No spam

Interested in doing business in Flanders?

Let us help you!

  • We can introduce you to other companies, banks and regulators
  • We organize site visits to real estate locations
  • We assist with all legal aspects of setting up a business
  • We're an official government agency
  • Our services are completely free
  • We are a team of international experts

Receive our handbook to growing your business in Flanders

  • It's completely free.
  • Get an overview of all incentives relevant to your company.
  • Tax system explained in-depth.
  • Learn how to set up your business quickly.
  • Discover the benefits of Flanders (in addition to the chocolate).

In addition to the ebook, I agree to receive one or two follow-up emails